CCR2 and neoplasm: We did not observe significant improvement in tumor growth or survival in DT-treated FoxP3DTRCcr2–/– mice beyond that seen in Ccr2–/– mice or FoxP3DTR mice treated with DT (Supplementary Fig. 10c).